A (b)(6) year old male patient with newly diagnosed glioblastoma (gbm) began optune therapy on (b)(6) 2020.Per medical record review, on (b)(6) 2020, patient was being treated for increased intracranial pressure with steroids (dexamethasone, 1 mg bid).At this time, steroid taper was begun with dexamethasone discontinued on (b)(6) 2020.On (b)(6) 2020, the patient experienced a grand mal seizure and was transported to the local emergency department.Patient's anti-seizure medication was increased and dexamethasone was restarted.Patient had a history of seizures and was taking anti-seizure medication at the time of the event.On (b)(6) 2020, head mri did not show gbm progression.Eeg showed no ongoing seizures.Per the prescribing physician, the cause of the seizure was likely due to underlying gbm and less likely due to optune.
|